Cipla Ltd
BSE:500087

Watchlist Manager
Cipla Ltd Logo
Cipla Ltd
BSE:500087
Watchlist
Price: 1 434.6 INR -0.9% Market Closed
Market Cap: 1.2T INR

Relative Value

The Relative Value of one CIPLA stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 434.6 INR, Cipla Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CIPLA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
44
vs Industry
27
Median 3Y
4.3
Median 5Y
4
Industry
2.7
Forward
3.9
vs History
98
vs Industry
19
Median 3Y
27.5
Median 5Y
28.8
Industry
21.6
Forward
23.3
vs History
36
vs Industry
15
Median 3Y
27.5
Median 5Y
25.2
Industry
16.9
vs History
71
vs Industry
11
Median 3Y
48.3
Median 5Y
49.6
Industry
22.9
vs History
90
vs Industry
17
Median 3Y
4
Median 5Y
3.9
Industry
2.3
vs History
47
vs Industry
29
Median 3Y
4
Median 5Y
3.7
Industry
3
Forward
3.5
vs History
82
vs Industry
33
Median 3Y
5.9
Median 5Y
5.9
Industry
5.6
vs History
88
vs Industry
22
Median 3Y
15.7
Median 5Y
16
Industry
13.4
Forward
14.9
vs History
93
vs Industry
22
Median 3Y
19.3
Median 5Y
20.5
Industry
16.7
Forward
17.9
vs History
38
vs Industry
17
Median 3Y
25.5
Median 5Y
23.3
Industry
16.1
vs History
28
vs Industry
13
Median 3Y
38.8
Median 5Y
34.4
Industry
18.9
vs History
57
vs Industry
16
Median 3Y
4.5
Median 5Y
4.2
Industry
2

Multiples Across Competitors

CIPLA Competitors Multiples
Cipla Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Cipla Ltd
BSE:500087
1.2T INR 4.1 21.3 14.7 17.4
US
Eli Lilly and Co
NYSE:LLY
966.6B USD 16.3 52.5 35.3 37.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
523.5B USD 5.7 20.8 17 22.1
CH
Roche Holding AG
SIX:ROG
276.2B CHF 4.5 29.3 12.4 14.5
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP 5.1 31.5 109.1 159.6
CH
Novartis AG
SIX:NOVN
222.2B CHF 5 19.3 12.2 15.8
US
Merck & Co Inc
NYSE:MRK
273.4B USD 4.3 14.4 10.2 12.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 10.9 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.7B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
IN
Cipla Ltd
BSE:500087
Average P/E: 24.4
21.3
4%
5.3
US
Eli Lilly and Co
NYSE:LLY
52.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.3
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
CH
Novartis AG
SIX:NOVN
19.3
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Cipla Ltd
BSE:500087
Average EV/EBITDA: 401.3
14.7
5%
2.9
US
Eli Lilly and Co
NYSE:LLY
35.3
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.4
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
109.1
10%
10.9
CH
Novartis AG
SIX:NOVN
12.2
6%
2
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Cipla Ltd
BSE:500087
Average EV/EBIT: 1 714
17.4
4%
4.4
US
Eli Lilly and Co
NYSE:LLY
37.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.1
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.8
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5